MarketCap
Facebook
X
TelegramMisonix, Inc. General and Administrative Expenses 2011-2026 | MSON
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Misonix, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 18 M | 11.9 M | 9.06 M | 9.6 M | 7.36 M | 5.98 M | 4.69 M | 4.45 M | 4.38 M | 4.5 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18 M | 4.38 M | 7.99 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Aziyo Biologics
AZYO
|
15.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 13.07 | -2.32 % | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
BioSig Technologies
BSGM
|
67.5 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
Electromed
ELMD
|
39.3 M | $ 25.6 | -0.56 % | $ 216 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.43 | 3.78 % | $ 128 M |  France |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
35.6 M | $ 0.62 | 3.18 % | $ 38.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
16.5 M | $ 10.53 | -4.96 % | $ 298 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |
 |
Globus Medical
GMED
|
1.18 B | $ 88.95 | -1.94 % | $ 12 B | USA |
 |
Eargo
EAR
|
54.3 M | - | - | $ 10.2 M | USA |
 |
Helius Medical Technologies
HSDT
|
9.27 M | $ 1.99 | -4.33 % | $ 1.21 M | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
Second Sight Medical Products
EYES
|
1.11 M | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
8.88 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.96 | -3.79 % | $ 1.05 B | USA |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Pulmonx Corporation
LUNG
|
101 M | $ 1.22 | -0.82 % | $ 49.6 M | USA |
 |
Orthofix Medical
OFIX
|
554 M | $ 11.61 | -2.52 % | $ 460 M |  Curacao |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 14.95 | -1.25 % | $ 351 M | USA |
 |
Delcath Systems
DCTH
|
43.5 M | $ 10.37 | -1.71 % | $ 371 M | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 177.51 | -3.05 % | $ 12.5 B | USA |
 |
IRIDEX Corporation
IRIX
|
7.73 M | $ 1.03 | -0.96 % | $ 17.4 M | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 36.55 | -0.65 % | $ 1.13 B | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 59.53 | -2.87 % | $ 3.25 B |  Britain |
 |
Inspire Medical Systems
INSP
|
625 M | $ 53.12 | -3.58 % | $ 1.56 B | USA |
 |
LENSAR
LNSR
|
45.2 M | $ 5.25 | -1.87 % | $ 62.8 M | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 83.84 | -0.99 % | $ 2.91 B | USA |
 |
Sintx Technologies
SINT
|
6.2 M | $ 2.1 | -2.12 % | $ 5.82 M | USA |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
2.09 B | $ 81.11 | -1.42 % | $ 47.4 B | USA |
 |
Tactile Systems Technology
TCMD
|
88.7 M | $ 22.92 | -2.76 % | $ 524 M | USA |
 |
TELA Bio
TELA
|
15.7 M | $ 0.76 | -2.56 % | $ 35.7 M | USA |
 |
Stryker Corporation
SYK
|
8.65 B | $ 312.51 | -2.79 % | $ 119 B | USA |
 |
MiMedx Group
MDXG
|
56.5 M | $ 3.28 | -3.68 % | $ 485 M | USA |